~~<i id='F53C8481E5'><strike id='F53C8481E5'><tt id='F53C8481E5'><pre id='F53C8481E5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：hotspot 2025-10-01 02:27:32 - browse：5658

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Involuntary treatment for addiction doesn't work

leisure time

hotspot

focus

entertainment

focus

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

WSS

Congress likely to miss an opportunity to fix drug shortages issue

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Peter Hotez and the public health issue of online harassment

focus

entertainment

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Medical records are filled with copy

Who gets to use the title 'doctor'?

Cancer drug shortages should be causing more outrage

Guidelines to prevent youth baseball injuries need more muscle

23andMe had bad news about my health. I wish a person had delivered it

Blood tests recalled over risk of missed heart attack diagnosis

New air purifier tech could be key to improving indoor air quality

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

hotspot

Blood tests recalled over risk of missed heart attack diagnosis

Who gets to use the title 'doctor'?

Activists slam private health insurers over coverage restrictions

Apple is now the first public company to be valued at $3 trillion

Georgia court denies Trump's request to quash DA's 2020 election probe

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

focus

focus

entertainment

focus